Interleukin-6 induces cellular insulin resistance in hepatocytes.
暂无分享,去创建一个
R. Mooney | I. Nowak | Joseph J Senn | Peter J Klover | Irena A Nowak | Robert A Mooney | P. Klover | J. Senn
[1] L Wood,et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.
[2] B. Spiegelman,et al. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Steensberg,et al. Muscle‐derived interleukin‐6: possible biological effects , 2001, The Journal of physiology.
[4] S. Ito,et al. Interleukin 1β and interleukin 6, but not tumor necrosis factor α, inhibit insulin‐stimulated glycogen synthesis in rat hepatocytes , 1998 .
[5] B. Posner,et al. Compartmentalization and insulin-induced translocations of insulin receptor substrates, phosphatidylinositol 3-kinase, and protein kinase B in rat liver. , 2000, Endocrinology.
[6] G. Shulman,et al. Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.
[7] A. Marette,et al. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle , 2001, Nature Medicine.
[8] E. Van Obberghen,et al. SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling* , 2000, The Journal of Biological Chemistry.
[9] D. Walsh,et al. The cancer anorexia-cachexia syndrome. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] E. Van Obberghen,et al. SOCS-3 Inhibits Insulin Signaling and Is Up-regulated in Response to Tumor Necrosis Factor-α in the Adipose Tissue of Obese Mice* , 2001, The Journal of Biological Chemistry.
[11] D. Hilton,et al. SOCS: physiological suppressors of cytokine signaling. , 2000, Journal of cell science.
[12] J. Kolls,et al. An in Vivo Model for Elucidation of the Mechanism of Tumor Necrosis Factor-α (TNF-α)-Induced Insulin Resistance: Evidence for Differential Regulation of Insulin Signaling by TNF-α. , 1998, Endocrinology.
[13] H. Sekihara,et al. Augmented Production of Tumor Necrosis Factor-α in Obese Mice , 1995 .
[14] M. White,et al. Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.
[15] Warren S. Alexander,et al. A family of cytokine-inducible inhibitors of signalling , 1997, Nature.
[16] S. Akira,et al. Signal Transducer and Activator of Transcription (Stat)-Induced Stat Inhibitor 1 (Ssi-1)/Suppressor of Cytokine Signaling 1 (Socs1) Inhibits Insulin Signal Transduction Pathway through Modulating Insulin Receptor Substrate 1 (Irs-1) Phosphorylation , 2001, The Journal of experimental medicine.
[17] J. Peschon,et al. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor , 1998 .
[18] H. Sauerwein,et al. Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. , 1996, Biochemical and biophysical research communications.
[19] T. Bártfai,et al. IL-6 is essential in TNF-alpha-induced fever. , 1998, The American journal of physiology.
[20] D. Papanicolaou,et al. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. , 1997, The Journal of clinical endocrinology and metabolism.
[21] S. Cameron,et al. Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor , 2001, The Journal of Biological Chemistry.
[22] U. K. Laemmli,et al. Cleavage of structural proteins during , 1970 .
[23] M. Papa,et al. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. , 1993, The Journal of biological chemistry.
[24] J. Pickup,et al. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. , 2000, Life sciences.
[25] W. Ricart,et al. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness , 1999, Diabetologia.
[26] G. Shulman,et al. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.
[27] A. Marette,et al. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. , 2001, The Journal of biological chemistry.
[28] Michael Karin,et al. Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.
[29] Margaret S. Wu,et al. Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice , 1997, Diabetes.
[30] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[31] J. Soria,et al. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes. , 2000, Cytokine.
[32] B. Spiegelman,et al. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. , 1994, The Journal of clinical investigation.
[33] J. Ulbrecht,et al. Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle. , 2000, American journal of physiology. Endocrinology and metabolism.
[34] J. Kolls,et al. Tumor Necrosis Factor-Induces Hepatic Insulin Resistance in Obese Zucker ( fa / fa ) Rats via Interaction of Leukocyte Antigen-Related Tyrosine Phosphatase With Focal Adhesion Kinase , 2000 .
[35] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[36] W. Ricart,et al. Interleukin-6 gene polymorphism and insulin sensitivity. , 2000, Diabetes.
[37] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.
[38] H. Sekihara,et al. Augmented production of tumor necrosis factor-alpha in obese mice. , 1995, Clinical immunology and immunopathology.
[39] C. Hardin. Making sense of oxygen sensing , 2001, The Journal of physiology.
[40] J S Yudkin,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .
[41] K. Claffey,et al. TNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12muscle cells. , 1999, American journal of physiology. Endocrinology and metabolism.
[42] T. Sasaoka,et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. , 2001, Diabetes.
[43] B. Evers,et al. Cytokine-mediated differential induction of hepatic activator protein-1 genes. , 1998, Surgery.
[44] K. Uysal,et al. Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.
[45] T. Shiba,et al. Hyperglycaemia due to insulin resistance caused by interferon‐γ , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[46] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[47] P. Heinrich,et al. Expression of suppressors of cytokine signaling during liver regeneration. , 2001, The Journal of clinical investigation.
[48] J. Kolls,et al. Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. , 2000, Diabetes.
[49] E. Van Obberghen,et al. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. , 1994, The Journal of biological chemistry.